Highbridge Capital Management’s Globus Medical GMED Stock Holding History

Highbridge Capital Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-5,915	Closed	-$295K	–	1073
2018 Q1	$295K	Buy	+5,915	New	+$278K	﹤0.01%	883
2016 Q4	–	Sell	-139,567	Closed	-$3.15M	–	1379
2016 Q3	$3.15M	Sell	139,567 -61,058	-30%	-$1.44M	0.05%	350
2016 Q2	$4.78M	Buy	200,625 +52,951	+36%	+$1.27M	0.08%	264
2016 Q1	$3.51M	Buy	+147,674	New	+$3.61M	0.06%	370
2015 Q4	–	Sell	-183,881	Closed	-$3.8M	–	1589
2015 Q3	$3.8M	Sell	183,881 -39,677	-18%	-$1M	0.06%	368
2015 Q2	$5.74M	Buy	+223,558	New	+$5.66M	0.07%	278
2015 Q1	–	Sell	-322,950	Closed	-$7.68M	–	1460
2014 Q4	$7.68M	Buy	322,950 +146,995	+84%	+$3.25M	0.1%	250
2014 Q3	$3.46M	Buy	+175,955	New	+$3.62M	0.05%	361

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Highbridge Capital Management's GMED Position: Q2 2018 in Review

Highbridge Capital Management sold out of Globus Medical (GMED) in Q2 2018, closing a stake of 5,915 shares — an estimated $295K sold.

Highbridge Capital Management first reported a position in GMED in Q3 2014 and held it in 8 quarters. The position peaked at $7.68M in Q4 2014. 290 funds tracked by Wall St. Rank hold GMED as of Q2 2018.

Highbridge Capital Management reported no remaining Globus Medical position as of Q2 2018 after selling out during the quarter.
Highbridge Capital Management sold 5,915 Globus Medical shares in Q2 2018, an estimated $295K.
Highbridge Capital Management first reported a position in Globus Medical in Q3 2014 and held it in 8 quarters.
Highbridge Capital Management's Globus Medical position peaked at $7.68M in Q4 2014.
290 funds tracked by Wall St. Rank held Globus Medical as of Q2 2018.

Based on Highbridge Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.